It's been a little painful in the short term watching us give up 30 cents only to gain back 20. Haven't seen any sustained progress after up days. Short of a news event, is the tide changing with fund interest such that we can see this run up perhaps to $4 ahead of any news?
Anything is possible, but if we look at history, even news like kings and fraun have not driven price up. I truly believe until any results are announced or leaked, this doesn't move much. But then again last Oct the stock went from 5 - 20 in a matter of hours so if you're long I wouldn't try to time it.....
This trial will investigate whether immunizations with an MVA recombinant HIV vaccine are safe and whether they will boost immune responses generated by immunizations with a dendritic cell (DC) targeted protein vaccine, DCVax-001, plus poly ICLC in healthy HIV-uninfected volunteers.
A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR , a Multigenic, Recombinant Modified Vaccinia Ankara HIV-1 Vaccine Expressing Env gp 150/Gag/Pol, in HIV-uninfected Healthy Volunteers Previously Immunized With Anti-DEC-205 Monoclonal Antibody (Mab) Targeted HIV Gag p24 Vaccine (DCVax-001) Plus Poly-ICLC (Hiltonol®) (RV 365 / WRAIR #2006).
The short answer is yes.
If you see the recently significantly increased institutional ownership and Dennis Mehiel taking an 8% passive stake in the company, you can only conclude that the share price will jump up very soon. There doesn't have to be news for that.
There is no other answer than "yes" to your question.